Watchmaker Genomics combines deep domain expertise in protein engineering with enzyme manufacturing to address the demanding quality, performance and scale requirements of high-growth genomics applications. We see our clients as partners and view technical and supply chain challenges as opportunities for mutual success. Watchmaker’s best-in-class scientific competencies enable a disruptive approach to life science partnerships.
Location: United States, Colorado, Boulder
Employees: 51-200
Total raised: $40M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 09.06.2022 | Eclipse Ve... | eclipse.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.06.2022 | Series A | $40M | Decheng Ca... |
Mentions in press and media 8
| Date | Title | Description |
| 27.05.2026 | Watchmaker Genomics recognized for excellence in exporting | Getting your Trinity Audio player ready... BOULDER — Watchmaker Genomics Inc., a biotechnology company developing advanced tools for genomic analysis, has been awarded the 2026 Governor’s Award for Excellence in Exporting. Already have an a... |
| 27.05.2026 | Angry Ferrari fans say the Italian company’s new EV is too Californian | Getting your Trinity Audio player ready... By Caroline Petrow-Cohen, Los Angeles Times Ferrari’s first-ever fully electric vehicle triggered some fans who said it looks more like an iPhone than an Italian supercar. The $640,000 Ferrari Luce... |
| 10.09.2024 | Volta Labs Announces First Customer Shipments and Expanding Preloaded App Menu | BOSTON, Sept. 10, 2024 /PRNewswire/ -- Volta Labs, a genomics applications company, announced today that the Callisto™ Sample Prep System has begun shipping to the first set of customers, with the first instrument going to the Icahn School ... |
| 10.04.2023 | Eclipse eclipses previous fundraises with a whopping $1.23 billion across two new funds | The market may be be tightening, but not for Eclipse Ventures, a Palo Alto-based venture firm that just raised $1.2 billion across two new funds. One fund, with $720 million in capital commitments, will be invested in early-stage outfits, a... |
| 13.06.2022 | Business Business | Watchmaker Genomics raises $40M in Series A | As the life sciences industry in the area continues to bloom, one of the newer companies in the region has completed a Series A funding round as it prepares to ramp up its research and development capabilities and expand its workforce. Watc... |
| 06.06.2022 | Why the fates of PE and VC-backed companies may diverge in 2022 | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. We’ve been hearing it for a few months now: There are rough times ahead for private companies. Pa... |
| 02.06.2022 | Watchmaker Genomics Raises $40M to Expand Clinical Sequencing Product Offerings | What You Should Know: – Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA raises $40M in an oversubscribed Series A, brin... |
| - | Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing | SOUTH SAN FRANCISCO, Calif. & BOULDER, Colo.--(BUSINESS WIRE)--Mar 2, 2021-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platf... |